Novartis joins membership

Feb 28, 2019
Novartis has joined the Chamber as a Corporate member. Novartis is reimagining medicine to improve and extend people's lives. As a leading global medicines company, they use innovative science and digital technologies to create transformative treatments in areas of great medical need. In their quest to find new medicines, they consistently rank among the world's top companies investing in research and development. Novartis products reach nearly 1 billion people globally and they are finding innovative ways to expand access to our latest treatments. About 125 000 people of more than 140 nationalities work at Novartis around the world.

Novartis operates in Latvia since 1996 and as SIA "Novartis Baltics" with affiliates in Estonia and Lithuania - since 2018. They are among top pharmaceutical manufacturers by sales value in the country. In Latvia Novartis is proud No 1 clinical trial sponsor. In the Chamber it will be represented by Dita Erna Sīle, Baltic Head of Patient Access and Public Affairs.

< Back to News


International School of Latvia


AmCham is a great place for networking, exchanging ideas and generating new business directions.

Peteris Kokovkins, Director of Baltic Technology Group

AmCham and PwC share the same values and targets to achieve socially.

Zlata Elksnina-Zascirinska, Country Managing Partner at PricewaterhouseCoopers